EpiCept Corporation Receives One-Month Extension to Loan and Security Agreement
October 19, 2012 00:01 ET
|
Immune Pharmaceuticals Inc
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced
today that MidCap Financial, LLC...
EpiCept Corporation Raises $0.8 Million from Immediate Exercise of Re-priced Warrants
September 25, 2012 00:26 ET
|
Immune Pharmaceuticals Inc
Series A and B Preferred Stock Conversion Prices Also Affected
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange...
EpiCept Regains Rights to Azixa® from Licensee Myrexis
September 05, 2012 00:01 ET
|
Immune Pharmaceuticals Inc
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced
today it has received notice of...
EpiCept Amends Loan and Security Agreement
August 31, 2012 00:01 ET
|
Immune Pharmaceuticals Inc
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced
today that it has amended the...
EpiCept Announces Changes to Its Board of Directors
August 30, 2012 00:01 ET
|
Immune Pharmaceuticals Inc
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced
today that A. Collier Smyth, Gerhard...
EpiCept Announces Resignation of CEO Jack Talley
August 21, 2012 17:45 ET
|
Immune Pharmaceuticals Inc
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com))-- Regulatory
News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced
today that Jack Talley has resigned as...
EpiCept Reports Second Quarter 2012 Operating and Financial Results
August 08, 2012 00:02 ET
|
Immune Pharmaceuticals Inc
CONFERENCE CALL BEGINS AT 9:00 A.M. EASTERN TIME TODAY
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX:...
EpiCept to Report Second Quarter 2012 Operating and Financial Results on August 8, 2012
August 02, 2012 17:00 ET
|
Immune Pharmaceuticals Inc
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced
today that it will host a conference...
EpiCept Transfers Ceplene Responsibilities in European Union and Sells License Rights to Meda
June 19, 2012 00:02 ET
|
Immune Pharmaceuticals Inc
ONLY TERRITORY ALREADY LICENSED TO MEDA AFFECTED
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)...
EpiCept Corporation to Present at 2012 BIO International Convention
June 12, 2012 17:01 ET
|
Immune Pharmaceuticals Inc
2012 BIO International Convention
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)...